ReviewCNS drugs2004
The generic alternative in schizophrenia: opportunity or threat?
Philippe Nuss et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCNS drugs2004
Philippe Nuss et al.PubMed ↗Publisher ↗
No numbers read from the abstract.